CANUTE PHARMA LIMITED

12545506
Active Manchester

Manufacture of medical and dental instruments and supplies

6 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and supplies
C

CANUTE PHARMA LIMITED

12545506

Manufacture of medical and dental instruments and supplies

Founded 3 Apr 2020 Active Manchester, United Kingdom 6 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and supplies

Previous Company Names

BRAEMAR PHARMA LTD 4 Oct 2024 — 20 Nov 2024
CANUTE PHARMA LIMITED 28 May 2020 — 4 Oct 2024
DERM NEWCO LIMITED 3 Apr 2020 — 28 May 2020
Accounts Due 31 Dec 2025 6 months overdue
Confirmation
Net assets £-839K £130K 2023 year on year
Total assets £1M £183K 2023 year on year
Total Liabilities £2M £313K 2023 year on year
Charges 10
5 outstanding 5 satisfied

Contact & Details

Contact

Registered Address

3rd Floor Northern Assurance Building Albert Square 9/12 Princess Street Manchester M2 4DN United Kingdom

Website

www.example.com

Full company profile for CANUTE PHARMA LIMITED (12545506), an active life sciences and medical technology company based in Manchester, United Kingdom. Incorporated 3 Apr 2020. Manufacture of medical and dental instruments and supplies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2024
Type total-exemption-full
Next accounts 31 Mar 2025
Due by 31 Dec 2025 6 months overdue

Net Assets, Total Assets & Total Liabilities (2020–2023)

Cash in Bank

£11.02k

Decreased by £83.34k (-88%)

Net Assets

-£839.48k

Increased by £130.46k (+13%)

Total Liabilities

£1.91M

Decreased by £313.48k (-14%)

Turnover

N/A

Employees

6

Decreased by 2 (-25%)

Debt Ratio

178%

Increased by 1 (+1%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Mar Year End
2023
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 1 resigned
Status
Anderson, Richard JamesDirectorBritishEngland603 Apr 2020Active

Shareholders

Shareholders (2)

Richard James Anderson
60.0%
Alison Whittaker
10.0%

Persons with Significant Control

Persons with Significant Control (3)

3 Active 1 Ceased

Richard James Anderson

British

Active
Notified 3 Apr 2020
Residence England
DOB April 1966
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Mr Richard James Anderson

British

Active
Notified 3 Apr 2020
Residence England
DOB April 1966
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent
  • Right To Appoint And Remove Directors

Mr Richard James Anderson

British

Active
Notified 3 Apr 2020
Residence England
DOB April 1966
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent
  • Right To Appoint And Remove Directors

Spencer Alan Kerry

Ceased 28 Sept 2022

Ceased

Group Structure

Group Structure

CANUTE PHARMA LIMITED Current Company

Charges

Charges

5 outstanding 5 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Second Floor 1 Royal Court, Tatton Street, Knutsford (WA16 6EN) CHESHIRE EAST
Leasehold-31 Jul 2020
Second Floor 1 Royal Court, Tatton Street, Knutsford (WA16 6EN)
Leasehold
Added 31 Jul 2020
District CHESHIRE EAST

Documents

Company Filings

DateCategoryDescriptionDocument
1 Jun 2026InsolvencyLiquidation Voluntary Statement Of Affairs
29 May 2026ResolutionResolutions
29 May 2026AddressChange Registered Office Address Company With Date Old Address New Address
29 May 2026InsolvencyLiquidation Voluntary Appointment Of Liquidator
21 May 2026Persons With Significant ControlChange to Mr Richard James Anderson as a person with significant control on 1 May 2026
1 Jun 2026 Insolvency

Liquidation Voluntary Statement Of Affairs

29 May 2026 Resolution

Resolutions

29 May 2026 Address

Change Registered Office Address Company With Date Old Address New Address

29 May 2026 Insolvency

Liquidation Voluntary Appointment Of Liquidator

21 May 2026 Persons With Significant Control

Change to Mr Richard James Anderson as a person with significant control on 1 May 2026

Recent Activity

Latest Activity

Liquidation Voluntary Statement Of Affairs

2 weeks ago on 1 Jun 2026

Resolutions

2 weeks ago on 29 May 2026

Change Registered Office Address Company With Date Old Address New Address

2 weeks ago on 29 May 2026

Liquidation Voluntary Appointment Of Liquidator

2 weeks ago on 29 May 2026

Change to Mr Richard James Anderson as a person with significant control on 1 May 2026

4 weeks ago on 21 May 2026